Product Details:
Payment & Shipping Terms:
|
CAS: | 5534-09-8 | Name: | Beclometasone Dipropionate |
---|---|---|---|
Purity: | 99%min | Shelf Life: | 2 Years |
High Light: | active pharmaceutical ingredient,pharmaceutical raw materials |
Beclometasone Dipropionate CAS:5534-09-8
English Name: Beclomethasone dipropionate
Another Name: Beclometasone Pressurised Inhalation ; (11beta,16beta)-9-chloro-11-hydroxy-16-methyl-3,20-dioxopregna-1,4-diene-17,21-diyl dipropanoate; [2](9Z,11E,13Z)-octadeca-9,11,13-trienoic acid
CAS: 4419-39-0
EINECS:226-886-0
Molecular formula: C28H37ClO7
Molecular weight: 521.04
Purity: ≥99%
Appearance:White or near white crystalline powder
Density:1.26 g/cm3 Melting Point:210 ºC Boiling Point:630.5 °C at 760 mmHg Flash Point:335.1 °C Solubility:Slightly soluble in water Each impurity: ≤0.5%
Total impurity: ≤1.0%
Function
1. It is highly effecitve glucosteroids.
2. No obvious influence on body temperature and micturition.
3. Effective on eczema, allergic dermatitis, neurodermitis, dermatitis contacta, psoriasis etc.
Application
1. renal cortex hormone, a potent topical corticosteroid drug, an anti-inflammatory, antiallergic and antipruritic effect, inhibits bronchial exudate, elimination of bronchial mucosal swelling, relieve bronchial spasm. Skin vasoconstriction effect far stronger than hydrocortisone hydrocortisone. Local anti-inflammatory effect was 5 times times the skin relaxed and ledercort. Lipophilic is strong, easy to penetrate, apply on the affected area take effect after 30 minutes.
2. also had no significant effect on temperature and urination. Thus, topical will not inhibit the human cortex and cortical dysfunction caused by adverse events. 3. topical treatment of inflammatory skin diseases such as eczema, atopic dermatitis, neurodermatitis, psoriasis, contact dermatitis, itching, etc. Aerosol can be used for chronic allergic rhinitis and allergic asthma, and so on.
Specification
Item | Specification | Result |
Appearance | White crystalline powder | Complies |
Related substance (HPLC) | Total impurity ≤0.5% Max single impurity ≤0.1% | 0.2% 0.06% |
Odor | Characteristic | Complies |
Assay | 99% | 99.8% |
Sieve analysis | 100% pass 80 mesh | Complies |
Loss on Drying Residue on Ignition | ≤1.0% ≤1.0% | 0.12% 0.09% |
Heavy Metal | <10ppm | Complies |
As | <0.1ppm | 0.05ppm |
Pb | <0.1ppm | 0.05ppm |
Cd | <0.1ppm | 0.05ppm |
Residual Solvents | <100ppm | Complies |
Residual Pesticide | Negative | Complies |
Microbiology | ||
Total Plate Count | <1000cfu/g | Complies |
Yeast & Mold | <100cfu/g | Complies |
E.Coli | Negative | Complies |
Salmonella | Negative | Complies |
Nootropics
Name | CAS | Purity |
CDP-Choline | 987-78-0 | ≥98% HPLC |
Citicoline sodium | 33818-15-4 | ≥98% HPLC |
Coluracetam (MKC-231) | 135463-81-9 | ≥99.0% HPLC |
Fasoracetam | 110958-19-5 | ≥99.0% HPLC |
Galantamine Hydrobromide | 1953-4-4 | ≥99.0% HPLC |
Huperzine A | 102518-79-6 | ≥1.0% and 99% HPLC |
Armodafinil | 112111-43-0 | ≥99.0% HPLC |
adrafinils | 63547-13-7 | ≥99.0% HPLC |
Hydrafinil (9-Fluorenol) | 1689-64-1 | ≥99.0% HPLC |
L-Alpha glycerylphosphorylcholine/ GPC | 28319-77-9 | 50%, 99% HPLC |
Phosphatidylserine | 51446-62-9 | ≥20%, 50% and 70% HPLC |
L-α-Phosphatidylcholine | 8002-43-5 | 70%, 50% |
Magnesium L-Threonate | 778571-57-6 | ≥95.0% Titration |
N-Acetyl-L-Tyrosine | 537-55-3 | 98%~102% HPLC |
Noopept | 157115-85-0 | ≥99.0% HPLC |
Oxiracetam | 62613-82-5 | ≥99.0% HPLC |
Phenibut | 1078-21-3 | ≥99.0% HPLC |
Phenylpiracetam | 77472-70-9 | ≥99% HPLC |
Pikamilone (Sodium) | 62936-56-5 | ≥98%~101%Titration |
Piracetam | 7491-74-9 | ≥99.0% HPLC |
Pramiracetam | 68497-62-1 | ≥98.0~102.0% HPLC |
Sulbutiamine | 3286-46-2 | ≥98.0% HPLC |
Sunifiram | 314728-85-3 | ≥99.5% HPLC |
Tianeptine Hemisukfate Monohydrate,tianeptine sulfate | 66981-73-5 | ≥98.0%~102.0% HPLC |
Tianeptine sodium | 30123-17-2 | ≥99.0% HPLC |
Vincamine | 1617-90-9 | ≥99.0% HPLC |
Vinpocetine | 42971-09-5 | ≥99.0% HPLC |
PRL-8-53 | 51352-87-5 | ≥99.0% HPLC |
NSI-189 | 1270138-40-3 | ≥99.0% HPLC |
IDRA-21 | 22503-72-6 | ≥99.0% HPLC |
Mexidol | 127464-43-1 | ≥99.0% HPLC |
agomelatine | 138112-76-2 | ≥99.0% HPLC |
5a hydroxy laxogenin | 56786-63-1 | ≥99.0% HPLC |
tadanafil | 171596-29-5 | ≥99.0% HPLC |
avanafil | 330784-47-9 | ≥99.0% HPLC |
Nootropics
Name | CAS | Purity |
CDP-Choline | 987-78-0 | ≥98% HPLC |
Citicoline sodium | 33818-15-4 | ≥98% HPLC |
Coluracetam (MKC-231) | 135463-81-9 | ≥99.0% HPLC |
Fasoracetam | 110958-19-5 | ≥99.0% HPLC |
Galantamine Hydrobromide | 1953-4-4 | ≥99.0% HPLC |
Huperzine A | 102518-79-6 | ≥1.0% and 99% HPLC |
Armodafinil | 112111-43-0 | ≥99.0% HPLC |
adrafinils | 63547-13-7 | ≥99.0% HPLC |
Hydrafinil (9-Fluorenol) | 1689-64-1 | ≥99.0% HPLC |
L-Alpha glycerylphosphorylcholine/ GPC | 28319-77-9 | 50%, 99% HPLC |
Phosphatidylserine | 51446-62-9 | ≥20%, 50% and 70% HPLC |
L-α-Phosphatidylcholine | 8002-43-5 | 70%, 50% |
Magnesium L-Threonate | 778571-57-6 | ≥95.0% Titration |
N-Acetyl-L-Tyrosine | 537-55-3 | 98%~102% HPLC |
Noopept | 157115-85-0 | ≥99.0% HPLC |
Oxiracetam | 62613-82-5 | ≥99.0% HPLC |
Phenibut | 1078-21-3 | ≥99.0% HPLC |
Phenylpiracetam | 77472-70-9 | ≥99% HPLC |
Pikamilone (Sodium) | 62936-56-5 | ≥98%~101%Titration |
Piracetam | 7491-74-9 | ≥99.0% HPLC |
Pramiracetam | 68497-62-1 | ≥98.0~102.0% HPLC |
Sulbutiamine | 3286-46-2 | ≥98.0% HPLC |
Sunifiram | 314728-85-3 | ≥99.5% HPLC |
Tianeptine Hemisukfate Monohydrate,tianeptine sulfate | 66981-73-5 | ≥98.0%~102.0% HPLC |
Tianeptine sodium | 30123-17-2 | ≥99.0% HPLC |
Vincamine | 1617-90-9 | ≥99.0% HPLC |
Vinpocetine | 42971-09-5 | ≥99.0% HPLC |
PRL-8-53 | 51352-87-5 | ≥99.0% HPLC |
NSI-189 | 1270138-40-3 | ≥99.0% HPLC |
IDRA-21 | 22503-72-6 | ≥99.0% HPLC |
Mexidol | 127464-43-1 | ≥99.0% HPLC |
agomelatine | 138112-76-2 | ≥99.0% HPLC |
5a hydroxy laxogenin | 56786-63-1 | ≥99.0% HPLC |
tadanafil | 171596-29-5 | ≥99.0% HPLC |
avanafil | 330784-47-9 | ≥99.0% HPLC |